Ying-Hua Luo Selected Research

Lung Neoplasms (Lung Cancer)

1/2021	18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells.
12/2020	Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways.
1/2020	10-HDA Induces ROS-Mediated Apoptosis in A549 Human Lung Cancer Cells by Regulating the MAPK, STAT3, NF-κB, and TGF-β1 Signaling Pathways.
1/2020	2-(6-Hydroxyhexylthio)-5,8-dimethoxy-1,4-naphthoquinone Induces Apoptosis through ROS-Mediated MAPK, STAT3, and NF-κB Signalling Pathways in Lung Cancer A549 Cells.
12/2019	Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species-mediated signaling pathways in human melanoma A375 cells.
11/2019	Quinalizarin induces ROS‑mediated apoptosis via the MAPK, STAT3 and NF‑κB signaling pathways in human breast cancer cells.
5/2019	New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways.
1/2019	The design of 1,4-naphthoquinone derivatives and mechanisms underlying apoptosis induction through ROS-dependent MAPK/Akt/STAT3 pathways in human lung cancer cells.
2/2018	Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-Hua Luo Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 12/2017
9	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2018
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 08/2017
4	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 01/2018
3	Breast Neoplasms (Breast Cancer) 11/2019 - 12/2017
2	Lymphoma (Lymphomas) 02/2019 - 02/2018
1	Carcinogenesis 12/2020
1	Melanoma (Melanoma, Malignant) 12/2019
1	Liver Neoplasms (Liver Cancer) 03/2019
1	Rheumatoid Arthritis 02/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 06/2018
1	Inflammation (Inflammations) 01/2018
1	Neuroinflammatory Diseases 07/2016

Drug/Important Bio-Agent (IBA)

9	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 01/2018
5	1,2,5,8-tetrahydroxy anthraquinoneIBA 12/2019 - 08/2017
4	1,4-naphthoquinoneIBA 01/2022 - 01/2018
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2019 - 01/2018
3	Oxygen (Dioxygen)IBA 09/2019 - 02/2019
3	Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2019
2	Sincalide FDA Link 12/2020 - 01/2020
2	ENDMNQIBA 03/2019 - 01/2019
2	EPDMNQIBA 03/2019 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 03/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 02/2019 - 01/2019
2	cryptotanshinoneIBA 02/2019 - 12/2017
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019 - 01/2018
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 02/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AcidsIBA 01/2021
1	LigandsIBA 01/2021
1	cytisineIBA 12/2020
1	liquiritinIBA 10/2020
1	Carotenoids (Carotene)IBA 01/2020
1	ZeaxanthinsIBA 01/2020
1	naphthaleneIBA 05/2019
1	Trypan Blue FDA Link 05/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2019
1	glyciteinIBA 01/2019
1	IsoflavonesIBA 01/2019
1	isoliquiritigenin (GU 17)IBA 01/2019
1	JNK Mitogen-Activated Protein KinasesIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 02/2018
1	NaphthoquinonesIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 12/2017
1	2,3-dimethoxy-1,4-naphthoquinoneIBA 07/2016

Therapy/Procedure

3	Therapeutics 01/2021 - 02/2018
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2021
1	Radiotherapy 01/2021